Navigation Links
Sofosbuvir: Indication of added benefit for specific patients
Date:5/2/2014

own who receives which treatment. This poses the risk that patients discontinue the study prematurely depending on which treatment they were randomized to. This compromises the aim of randomization: the comparability of the treatment groups. This is exactly what happened in the FISSION study, which may lead to (highly) biased results.

Mortality and quality of life: added benefit not proven

As no deaths occurred in the FISSION study in the therapeutic indication genotype 2, there could be no differences between the treatment groups, and therefore no proof of added benefit, in the outcome "mortality". This also applies to health-related quality of life, but in this case because the dossier contained no evaluable data for this outcome.

Advantage in sustained virologic response

Instead of the patient-relevant outcome "development of hepatocellular carcinoma (HCC)", the manufacturer used sustained virologic response (SVR). It could show that there was a statistically significant group difference in favour of sofosbuvir. IQWiG conducted its own sensitivity analyses because of the high risk of bias. It tested how the effects changed when missing values were imputed with different strategies. The researchers found out that the result in favour of sofosbuvir was robust.

Valid surrogate for incidence of liver cancer

SVR is not itself a patient-relevant outcome and cannot be equated with "cure", and there are no studies in which SVR is validated as a surrogate outcome in accordance with the usual criteria employed by IQWiG. Nevertheless, the Institute accepts SVR here as a surrogate for the reduced incidence of liver cancer. This is because it is currently accepted that patients with no detectable hepatitis C virus in the blood are at lower risk of liver cancer. However, it is unclear how many cases of liver cancer can in fact be prevented by sofosbuvir.

For the outcome "secondary diseases", I
'/>"/>

Contact: Dr. Anna-Sabine Ernst
presse@iqwig.de
49-022-135-6850
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Finnish research to revolutionise indications for knee surgery
2. Southwest Skin and Cancer Institute Employs Botox for New Indications
3. Global Vaccine Market Trends and Disease Indications Analysis with 2022 Forecasts in New Research Report at RnRMarketResearch.com
4. Apixaban in atrial fibrillation: Indications of considerable added benefit
5. Aflibercept in colorectal cancer: Indication of minor added benefit
6. Global Critical Care Market Will Reach $3.2 Billion in 2019 - Growth from Factor Concentrates, New Indications and Increasing Demand for Albumin in Asia-Pacific
7. Indication of considerable added benefit of vemurafenib in advanced melanoma
8. Antibody-coated stents: Indication of disadvantages
9. Abiraterone: Indication of considerable added benefit in certain patients
10. Turoctocog alfa in patients with hemophilia A: Added benefit not proven
11. Geriatric health professionals experience added burden when caring for own family members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... (PRWEB) July 29, 2014 Many people complain ... thing they do each morning is put on glasses to ... These same individuals also may be dissatisfied with their ... , Cataracts may cause difficulty driving, especially at night ... follow or find one’s golf ball, see the TV, sew ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Tylenol ... individuals who allegedly suffered serious liver injuries due ... move forward in a multidistrict litigation underway in ... Liebhard LLP reports. According to an Order dated ... deadlines pertaining to bellwether case and discovery issues. ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 New high ... Medicare Part D by a projected $2.9 to $5.8 ... the actuarial firm Milliman released today by the Pharmaceutical ... D premiums could increase by as much as 8.6 ... C drugs, including Sovaldi and Olysio. , The study ...
(Date:7/29/2014)... Historically, Memorial Day kicks off a three ... throughout that time by picnics, barbecues and beach outings. ... the start of a period that will witness a ... 2012 nearly 1.000 people were killed in crashes involving ... Labor Day. , The summer's warmer weather, longer days ...
(Date:7/29/2014)... Alan Mozes HealthDay Reporter ... certain adult autism patients with just a single dose of ... expressions and emotions, Japanese researchers report. Known as the ... in emotional bonding between lovers, and between mothers and their ... in a key area of the brain that has long ...
Breaking Medicine News(10 mins):Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: Federal Court Overseeing Tylenol Liver Damage Claims Sets New Deadlines Pertaining to Discovery, Bellwether Trials, Bernstein Liebhard LLP Reports 4Health News:New Milliman Study: Hepatitis C Drugs Could Increase Medicare Part D Spending by $2.9 to $5.8 Billion in 2015 2Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 2Health News:'Love Hormone' Oxytocin May Help Some With Autism 3
... after having their tonsils and adenoids removed to treat ... over time they may relapse or even worsen. African-American ... from Cincinnati Childrens Hospital Medical Center. , Adenotonsillectomy ... from about 19 per 10,000 in Canada to 115 ...
... 14 Murad, where skincare,meets healthcare(R), today ... the,company,s new Vice President of Global Marketing ... pivotal lead in driving brand growth and ... market,opportunities, driving product development, increasing brand profitability,and ...
... Policy Changes in Handling Credit ... ... today that he has reached a settlement with TransUnion over his,lawsuit against ... TransUnion is the first of six credit reporting companies and banks,which ...
... - Body Mass Index (BMI), the measure of a person,s ... effective prognostic tool for specific types of breast cancer, according ... Cancer Center. , The study, published in the March 15 ... breast cancer (LABC) and inflammatory breast cancer (IBC) with high ...
... PHILADELPHIA Women with breast cancer have more aggressive ... or obese, according to findings published in the March ... the American Association for Cancer Research. , The ... disease, said Massimo Cristofanilli, MD, associate professor of medicine ...
... MNKD ), focused on discovering, developing and,commercializing treatments ... at the Cowen and Company Healthcare Conference on March ... Place Hotel in Boston, MA., Interested parties can ... the,presentation in the Investor Relations section of the Company,s ...
Cached Medicine News:Health News:The ABCs of childhood z's: Snoring may be chronic despite surgery 2Health News:Murad, Inc., Hires Lori Jacobus as Vice President of Global Marketing 2Health News:Leukemia Survivor Reaches Landmark Settlement With TransUnion in ID Theft Case 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 3Health News:Breast cancer more aggressive among obese women 2
(Date:7/29/2014)... , July 29, 2014  EnteroMedics Inc. (NASDAQ: ... neuroblocking technology to treat obesity, metabolic diseases and other ... conference call on Thursday, August 7, 2014 at 11:00 ... second quarter ended June 30, 2014 and to provide ... The second quarter conference call may be accessed ...
(Date:7/29/2014)... GLENWOOD, Ill. , July 29, 2014  Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... will release financial results for the fiscal third quarter ... 2014. The Company will host a ... at 9:00 a.m. Central Time (10 a.m. Eastern Time). ...
(Date:7/29/2014)... Corporation (NYSE: EW ), the global leader in ... net income for the quarter ended June 30, 2014 of ... income of $94.0 million, or $0.88 per diluted share.  Net ... million, or $0.81 per diluted share, and non-GAAP net income ... Net sales for the quarter ended June 30, 2014 ...
Breaking Medicine Technology:EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2014 Results 2Edwards Lifesciences Reports Strong Second Quarter Results 2Edwards Lifesciences Reports Strong Second Quarter Results 3Edwards Lifesciences Reports Strong Second Quarter Results 4Edwards Lifesciences Reports Strong Second Quarter Results 5Edwards Lifesciences Reports Strong Second Quarter Results 6Edwards Lifesciences Reports Strong Second Quarter Results 7Edwards Lifesciences Reports Strong Second Quarter Results 8Edwards Lifesciences Reports Strong Second Quarter Results 9Edwards Lifesciences Reports Strong Second Quarter Results 10Edwards Lifesciences Reports Strong Second Quarter Results 11Edwards Lifesciences Reports Strong Second Quarter Results 12Edwards Lifesciences Reports Strong Second Quarter Results 13Edwards Lifesciences Reports Strong Second Quarter Results 14Edwards Lifesciences Reports Strong Second Quarter Results 15Edwards Lifesciences Reports Strong Second Quarter Results 16Edwards Lifesciences Reports Strong Second Quarter Results 17Edwards Lifesciences Reports Strong Second Quarter Results 18Edwards Lifesciences Reports Strong Second Quarter Results 19Edwards Lifesciences Reports Strong Second Quarter Results 20Edwards Lifesciences Reports Strong Second Quarter Results 21Edwards Lifesciences Reports Strong Second Quarter Results 22Edwards Lifesciences Reports Strong Second Quarter Results 23Edwards Lifesciences Reports Strong Second Quarter Results 24Edwards Lifesciences Reports Strong Second Quarter Results 25
... Calif., Sept. 13, 2011 Edison Pharmaceuticals, Inc. announced ... Financing. Capital raised will fund US and European approval ... Terms of the financing were not disclosed. ... Pharmaceuticals is a patient- and physician-founded company devoted to ...
... a leader in Quality of Daily Life Solutions announced ... the agreement, Sodexo will offer technology-enabled solutions by Healthsense ... Sodexo,s current offerings to realize their vision of improved ... communities they serve.   Healthsense is an ...
Cached Medicine Technology:Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 2Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 3
Colloidal Gold Conjugated, Protein A - 12 OD...
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Conjugated, Protein G - 12 OD...
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: